A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

November 18, 2017

Study Completion Date

December 15, 2017

Conditions
Healthy Volunteer
Interventions
DRUG

Alprazolam Placebo

100 mg lactose tablets

DRUG

Cenobamate placebo

Sugar pill manufactured to mimic cenobamate 100 mg tablet

DRUG

Alprazolam

0.5 mg and 1.0 mg alprazolam tablets

DRUG

Cenobamate

100 mg tablet

Trial Locations (2)

66212

Vince & Associates Clinical Research, Inc, Overland Park

M5V 2T3

INC Research, Inc., Toronto

All Listed Sponsors
lead

SK Life Science, Inc.

INDUSTRY

NCT03509285 - A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users | Biotech Hunter | Biotech Hunter